Scientific Program

The Scientific Committee has put together an outstanding program. Kindly note that the program is subject to change.

Abstract Book

Click here to download a pdf of the program (Last updated October 16, 2015)

Thursday, October 22, 2015

09:00 – 17:00 Exclusive Tour for ITMIG Members: Full Day Shanghai Highlights

17:30 – 20:30 Exclusive Tour for ITMIG Members: Optional Shanghai Night Tour

Friday, October 23, 2015

12:00 - 20:30 Committee Meetings
12:00 – 13:00 Research & Infrastructure / Clinical Trials
13:00 – 14:00 Education Committee
14:00 – 15:00 Outlier Working Group
15:00 – 15:30 Biology Working Group
15:30 – 17:00 Database Committee
17:00 – 18:00 Mediastinal WG
18:00 – 19:00 Regional Champions
19:00 – 20:00 ChART and ITMIG Collaboration
20:00 – 20:30 Membership Committee
20:30 Welcome Reception

Saturday, October 24, 2015

08:00 – 08:30 ITMIG Business Meeting
08:30 – 08:35 Industry Introduction
08:35 – 10:05 Invited Speaker Session 1: Asian Session – Contributions of Chart, Jart, and Korea
Chair: Wentao Fang, China & Jun Nakajima, Japan

  • Overall Results of ChART Retrospective Database
  • Induction Therapies for Advanced Thymic Tumors
  • Validation of the ITMIG Proposal of New Staging
  • Total Thymectomy vs Partial Thymectomy – Kazuhiko Nakagawa, Japan
  • Surgical Outcome of Thymic Carcinoma - Tomoyuki Hishida, Japan
  • Korea: Korean Multicenter Database for Thymic Epithelial Tumor - Chang-Hyun Kang, South Korea
10:05 – 10:40 Networking Break, Poster Viewing and Exhibit Tour
10:40 – 12:00 Invited Speaker Session 2: Minimally Invasive Thymectomy (MIT) Session
Chairs: Robert Korst, USA & Marlies Keijzers, Netherlands

  • Robot vs. VATS Thymectomy: Which One Do I Choose – Alper Toker, Turkey
  • Technical Aspects in VATS Thymectomy - Vincent Fang, USA
  • Innovative Lecture: The Ethics of Innovation in a Rare Disease
  • Panel Discussion
12:00 – 12:30 Johnson & Johnson Lunch Session

  • The Use of Ultrasonic Energy in Thoracic Surgery - Shastri Satyanand, India
12:45 – 13:15 Medtronic Lunch Session

  • Challenging VATS – Hyeong Ryul Kim, Korea
12:00 – 13:30 Lunch
13:30 – 15:00 ITMIG Updates
Chairs: James Huang, USA & Nicolas Girard, France

  • Overview of the Database and the Process for Analyses – James Huang, USA
  • Brief Recap of ITMIG Retrospective DB Analyses
    • Thymic Carcinoma Overview – Enrico Ruffini, Italy
    • Thymic Carcinoid Overview - Enrico Ruffini, Italy
    • WHO and Importance of Histotype - Cleo-Aron Weis, Germany
    • Efficacy of PORT in Completely Resected Thymoma - Robert Korst, USA
    • Minimally Invasive vs. Open Resections for Thymic Malignancies - Bryan Burt, USA
    • Paraneoplastic Syndromes in Thymic Malignancies - Sukhmani Padda, USA
    • Subtotal vs. Total Thymectomy - Brian Louie, Sweden
  • Prospective DB and Research Process and Future Projects - Nicolas Girard, France & Robert Korst, USA
15:00 – 15:30 Networking Break, Poster Viewing and Exhibit Tour
15:30 – 16:30 ORAL 1 – Abstract Session 1: Molecular Biology and Chemotherapy
Chairs: Heather Wakelee, USA & Sanghoon Jheon, Korea

  • Phase II Trial of Amrubicin in Patients with Previously Treated Advanced Thymic Malignancies – Heather Wakelee, USA
  • Sunitinib in Patients with Advanced Thymic Epithelial Tumors (TET) – Nicolas Girard, France
  • Frequent  PD-L1 Expression in Thymic Squamous Cell Carcinoma of Chinese Patients – Hong Jian, China
  • MicroRNA Networks: Novel Key Regulators in Thymic Epithelial Tumors – Mirella Marino, Italy
16:45 – 17:45 ORAL 2 – Abstract Session 2: Treatment and Novel Approaches
Chairs: Conrad Falkson, Canada & Norihiko Ikeda, Japan

  • Proton Beam Radiation Therapy for Adjuvant and Definitive Treatment of Thymoma and Thymic Carcinoma – Jennifer Vogel, USA
  • The Role of Postoperative Radiotherapy for Stage I/II/III Thymic Tumor–Results of ChART Database – Jian-Hua Fu, China
  • S-1 Salvage Treatment for Chemorefractory Stage IV Thymic Carcinoma: A Report of 19 Cases – Changlu Wang, China
  • Expression and Significance of C-Kit and EMT Molecules in Thymic Epithelial Tumors – Chen Chun, China
17:45 – 18:30 Reception
18:30 ITMIG Dinner
Restaurant: Shui Bo Xiang Long, 11F, Huarong Building, 15, Zhong Shan Dong Er Road, Shanghai

Sunday, October 25, 2015

07:00 – 08:00 Medela Breakfast Session: Streamlining Thoracic Surgical Care

  • Key Components of a Streamlined Care System – Frank Detterbeck, USA
  • Intra- and Post-Operative Chest Tube Management – Alan Sihoe, Hong Kong
  • Avoidence of Prolonged Airleak – Gaetano Rocco, Italy
08:00 – 09:30 Invited Speaker Session 3: Clinical Research
Chair: Sukhmani Padda, USA & Robert Korst, USA

  • Update on the Global Asset Project - Frank Detterbeck, USA
  • Ongoing Clinical Trials - Heather Wakelee, USA
  • Innovative Lecture on Outlier Analysis - Frank Detterbeck, USA
  • Outlier Analysis – Robert Korst, USA
09:45 – 10:45 ORAL 3 – Abstract Session 3: Regional Trends
Chairs: Alan Sihoe, Hong Kong & Zhenao Yu, China

  • Malignant Thymoma Incidence in a Chinese Population – Chunxiao Wu, China
  • Postoperative Survival for Patients with Thymoma Complicating Myasthenia Gravis – ChART Experience – Liewen Pang, China
  • Increasing Number of Thymectomies Performed in the United States – Dan Raz, USA
  • The Extent of Lymph Node Dissection in Thymic Malignancies - In Kyu Park, Korea
10:45 – 11:15 Networking Break, Poster Viewing and Exhibit Tour
11:15 – 12:15  Invited Speaker Session 4: Mediastinum
Chairs: Anja Roden, USA & Mirella Marino, Italy

  • Mediastinal Cysts: Radiologic Features, Management Strategy, Surgical Approaches – Panel Discussion: Yan Shen, China & Lei Zhu, China & Zhitao Gu, China
  • The Mediastinal Working Group Survey (Tumors Other than Thymoma) – Anja Roden, USA and Discussion
12:15 – 13:30 Lunch
13:30 – 14:30 ORAL4 – Abstract Session 4: Patient Evaluation
Chairs: Edith Marom, Israel & Meinoshin Okumura, Japan

  • Comparison between CT and MRI in Preoperative Evaluation of Thymic Epithelial Tumors – Edith Marom, Israel
  • Dynamic Contrast-Enhanced MR Imaging in Risk Stratification of Thymic Epithelial Tumors – Yan Shen, China
  • Needs Assessment and Design of the First Thymic Malignancy and Myasthenia Gravis Program – Jennifer Vogel, USA
  • Emergency Presentation of Mediastinal Tumors: A Clinicopathological Study – Abdulhadi Almutairi, Saudi Arabia
14:30 – 15:30 Session 5: Tumor Board
Chair: Frank Detterbeck, USA & Benny Weksler, USAThe ITMIG virtual tumor board has been initiated, allowing cases from around the world to be discussed with a panel of experts. In this session we will carry out such a tumor board. We encourage participants to submit cases for discussion (contact Pam Bruce for information on how to submit the necessary data for discussion).
15:30 – 16:00 Networking Break, Poster Viewing and Exhibit Tour
16:00 – 17:00 Invited Speaker Session 6: Basic Science
Chair: Nicholas Girard, France & Alexander Marx, Germany

  • Cell-Cell Interaction Pathways in the Thymus - Yousuke Takahama, Japan
  • Driving Translational Research from Routine Practice: How to Build a Thymic Tumor Bank at My Institution? - Nicholas Girard, France
  • TCGA: Identifying Pathways and Targets for a Better Understanding of the Disease and Develop New Precision Medicine Approaches - Jean Claude Zenklusen, USA
17:00 – 17:15 Awards, Closing Remarks
18:00 Informal Dinner (all ITMIG delegates invited, however, dinner expenses are on your own)

Monday, October 26, 2015

08:00 – 11:30 Shanghai Chest Hospital Tour
Visit the biggest thoracic oncology center in China while you are in Shanghai for the 2015 ITMIG annual meeting! You are welcome to meet thoracic surgeons, medical and radiation oncologists, pathologists, and radiologists who are seeing over 10,000 lung cancers, 1000 esophageal cancers, and 1000 mediastinal lesions every year. Take this chance to build friendship and seek potential collaboration with Chinese colleagues!

  • 08:00 - Pickup service from Regal Hotel to the Shanghai Chest Hospital
  • 08:30 - Brief introduction of the hospital. Meeting with people from all specialties
  • 09:00 - Tour of the hospital together with individual staffs of the hospital
  • 11:00 - Transportation back to the Regal Hotel

Poster Presentations

  • Poster Setup Time: 08:00 – 10:00 on Saturday, October 24
  • Poster Take Down: 17:30 – 18:30 on Sunday, October 25
  • Author Stand by Time: You are required to be at your poster board during the Coffee Breaks (morning and afternoon) on the day of your poster session, so delegates have the chance to discuss your work with you and ask questions. Thank you for your support!
  • Poster Size: The standard poster size is 0.9 meter in width by 1.2 meter in height. Any nails or pins are NOT allowed in order to protect the panel from damage. Only double-sided sponge-type tape can be applied. Stickers and tapes will be provided onsite.

Click here to download a pdf of poster presentations (Last updated October 14, 2015)

P01: Long-Term Survival after Surgical Treatment of Thymic Carcinoma
Hao Fu, China
P02: Comparison a Novel 3-Hole Surgery with VATS for Myasthenia Gravis: A Retrospective Study
Qiang Lu, China
P03: Thymic Neuroendocrine Tumors: Analysis of Factors Affecting Survival
Benny Weksler, USA
P04: Elevated Serum LDH Level Predicts Both Poor OS and Short RFS after Resection of Thymic Carcinoma
Qian-wen Liu, China
P05: Low-Dose Radiotherapy for the Treatment of Pleural Recurrence of Thymic Carcinoma
Changlu Wang, China
P06: A New Surgical Method for Anterior Mediastinum Tumors: A 3-Hole Approach
Yongan Zhou, China
P07: Effectiveness of Cytotoxic Agent Etoposide after Target Therapy in Advanced Thymic Tumors
Margaret Ottaviano, Italy
P08: Somatostatin Analogs plus Prednisone in Aggressive Histotype and Advanced Stage of TETs
Margaret Ottaviano, Italy
P09: Diagnosis of Advanced Thymic Epithelial Tumors in Patients Previously Affected by Thymic Hyperplasia
Giovannella Palmieri, Italy
P10: Is the Octreoscan Score a Predictive Factor of Response to Somatostatin Analogs Treatment?
Giovannella Palmieri, Italy
P11: 18FDG-PET/CT for Early Prediction of Response to First Line Platinum Chemotherapy in Advanced TETs
Giovannella Palmieri, Italy
P12: Somatostatin Analogs as Maintenance Therapy in Heavily Pretreated Thymic Epithelial Tumors
Giovannella Palmieri, Italy
P13: Establishment and Charactrization of a Novel Human Thymoma Cell Line
Qiangling Sun, China
P14: Feasibility Of “Subxiphoid and Subcostal” Approach in VATS Thymectomy for Patients with MG
Qiao Bin, China
P15: The Expression of tc17 Cells in Thymoma Accompany with Autoimmune Diseases or Autoimmune Disorders
Peng Zhang, China
P16: The Impact of Thymoma Cell Apoptosis After Down Wnt4 Gene
Peng Zhang, China
P17: Do Associated Auto-Antibodies Influence the Outcome of Myasthenia Gravis after Thymectomy?
Marlies Keijzers, Netherlands
P18: Thoracoscopic Complete Thymectomy for Thymoma
Takahiro Iida, Japan
P19: Combined Transcervical and Bilateral-Thoracoscopic Extended Thymectomy for Thymoma with MG
Jian-yong Ding, China
P20: Expression and Clinical Significance of Autoimmune Regulator in Thymomas with Autoimmune Disease
Peng Zhang, China
P21: To Explore the Value of Qiangji Jianli Method for the MG Patients Underwent Extended Thymectomy
Yanzhong Liu, China
P22: The Clinical Value of Biomarker in the Thymic Tumors
Zhexin Wang, China
P23: Tumor Volume of Thymic Epithelial Tumors Based on WHO Histological Classification
Yukihisa Sato, Japan
P24: The Predictive Role of the WHO Histological Classification in the Treatment of Advanced Thymoma
Tetsuzo Tagawa, Japan
P25: VATS Combined with a Subxiphoid Incision: A Novel Approach for Large Thymoma
Jian-yong Ding, China
P26: Analysis of Immune Makers and Clinical Significance in Thymomas with Autoimmune Disease in Thymoma
Peng Zhang, China
P27: Induction but Not Extrapleural Pneumonectomy May Be Important in the Treatment for Stage Iva Thymoma
Xinghua Cheng, China
P28: Pridictors and Management for the Primary IVa Thymoma
Lanting Gao, China
P29: Evolution of Minimally Invasive Surgery in the Management of Thymic Masses at a Single Institution
Anna Tam, Singapore
P30: A Case of Anterior Mediastinitis and Bilateral Multiple Lung Abscesses Occurring after TsTET
Yun Wang, China
P31: Salvage Surgery for PMGCT: Beneficial for Persistent Positive-Marker Patients?
Takashi Sakai, Japan
P32: Comparing Radiotherapy with Free Breathing and Deep Inspiration Breath Hold for Thymic Cancers
Kristoffer Rohrberg, Denmark
P33: Predictive Factors of Extended Thymectomy for Myasthenia Gravis
Naoya Himuro, Japan
P34: The Clinical Analysis of Subxiphoid Approach of VATS Anterior Mediastinal Mass Extended Resection
Chun Chen, China
P35: Study on the Loss of Heterozygosity of Microsatellite Allele in Thymic Epithelial Tumors
Peng Zhang, China
P36: Thoracoscopic Resection of Bulky Thymoma Using Artificial Pneumothorax
Hui Zhang, China
P37: Locally Advanced Thymoma – Robotic Approach
Belal Asaf, India
P38: Reoperation for Recurrent Thymoma: A Single-Center Experience from Nanchang
Yangchun Liu, China
P39: Effects of TNIP1/TNFAIP3 Expression: Implications for Myasthenia Gravis
Yingtsai Gung, China
P40: Does IL8 (CXCL8) Have a Role in Thymoma Progression and as a Marker for Relapse?
Yin Wu, UK